Literature DB >> 10155267

Identifying costs of intravenous solution wastage.

K M Uchida1, S A Iteen, N T Wong.   

Abstract

A monitoring programme to systematically evaluate and decrease wastage of intravenous (i.v.) solutions was developed. Documentation of type and quantity of wasted solutions can help identify potential causes of waste. Subsequent systems changes intended to decrease waste can then be evaluated. Pharmacy technicians daily recorded the number, identity and locations of discarded i.v. solutions. A computer spreadsheet application was developed and used to produce a monthly summary identifying the number, drug cost and solutions wasted by hospital unit, thus establishing specific areas to target for i.v. wastage control. Investigators conducted a 12-month retrospective evaluation of i.v. wastage, revealing that over 14,000 i.v. preparations were destroyed at an estimated $US90,000 in drug costs. This equates to 2.5% of total drug costs wasted in small volume parenterals. Target programmes were implemented for drugs that were frequently wasted and systems changes implemented that decreased overall wastage of i.v. solutions.

Mesh:

Substances:

Year:  1994        PMID: 10155267     DOI: 10.2165/00019053-199406030-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  7 in total

1.  Cost of wastage in a hospital intravenous admixture program.

Authors:  D J Salberg; R W Newton; D T Leduc
Journal:  Hosp Formul       Date:  1984-05

2.  Survey of wastage from intravenous admixture in US hospitals.

Authors:  S W Birdwell; G E Meyer; D J Scheckelhoff; C S Giambrone; S A Iteen
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

3.  Reducing i.v. waste to under 2.25 percent.

Authors:  J G Newhouse; V M Paul; N A Waugh; C B Frye
Journal:  Hosp Pharm       Date:  1988-03

4.  Reducing waste of intravenous solutions.

Authors:  L D Diehl; E D Goo; L Sumiye; R Ferrell
Journal:  Am J Hosp Pharm       Date:  1992-01

5.  Waste of i.v. admixtures in the ADD-Vantage system and a traditional minibag system.

Authors:  M Billeter; M M Nowak; R P Rapp; M L Hunt
Journal:  Am J Hosp Pharm       Date:  1990-07

6.  Monitoring waste in an intravenous admixture program.

Authors:  S R Mitchell
Journal:  Am J Hosp Pharm       Date:  1987-01

7.  ASHP technical assistance bulletin on assessing cost-containment strategies for institutional pharmacies.

Authors: 
Journal:  Am J Hosp Pharm       Date:  1985-07
  7 in total
  4 in total

1.  Validating hospital antibiotic purchasing data as a metric of inpatient antibiotic use.

Authors:  Charlie Tan; Michael Ritchie; Jason Alldred; Nick Daneman
Journal:  J Antimicrob Chemother       Date:  2015-11-05       Impact factor: 5.790

Review 2.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

3.  Evaluation and implementation of strategies to reduce the intravenous admixture returns.

Authors:  Ahmed A Alrashed; Yahya Ali Mohzari; Syed Mohammed Basheeruddin Asdaq
Journal:  Saudi J Biol Sci       Date:  2020-11-11       Impact factor: 4.219

4.  Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial.

Authors:  Joan Webster; Samantha Clarke; Dana Paterson; Anne Hutton; Stacey van Dyk; Catherine Gale; Tracey Hopkins
Journal:  BMJ       Date:  2008-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.